IFNG and neoplasm: Patients with tumors that do not respond to immune-checkpoint inhibition often harbor a non-T cell-inflamed tumor microenvironment, characterized by the absence of IFN-γ-associated CD8<sup>+</sup> T cell and dendritic cell activation.